ZRSR2 mutations typically involve inactivation and are predominantly found in males. They are more common in MDS subtypes lacking ring sideroblasts and are linked to increased bone marrow blasts, reduced survival, and a higher likelihood of progressing to AML (36). Here, ZRSR2 is linked to acute myeloid leukemia.